David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$397M |
| 2 |
YHOO
Yahoo Inc
YHOO
|
+$342M |
| 3 |
Bank of America
BAC
|
+$322M |
| 4 |
Citigroup
C
|
+$260M |
| 5 |
Booking.com
BKNG
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$637M |
| 2 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$397M |
| 3 |
Gilead Sciences
GILD
|
+$358M |
| 4 |
Phillips 66
PSX
|
+$330M |
| 5 |
Apple
AAPL
|
+$320M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.78% |
| 2 | Technology | 11.11% |
| 3 | Financials | 10% |
| 4 | Consumer Discretionary | 8.83% |
| 5 | Communication Services | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SFLY
651
DELISTED
Shutterfly, Inc.
SFLY
| $14.7M | 0.03% |
318,064
+79,029
| +33% | +$3.37M |
|
652
CALL
Blackrock
BLK
$180B
| $14.7M | 0.03% |
43,300
-10,000
| -19% | -$3.17M |
|
|
AVG
653
DELISTED
AVG Technologies N.V.
AVG
| $14.7M | 0.03% |
708,983
+226,795
| +47% | +$4.25M |
|
|
RPXC
654
DELISTED
RPX Corporation
RPXC
| $14.7M | 0.03% |
1,306,382
+98,785
| +8% | +$1.05M |
|
|
ANSS
655
DELISTED
Ansys
ANSS
| $14.7M | 0.03% |
164,406
+120,964
| +278% | +$10.4M |
|
656
Sarepta Therapeutics
SRPT
$1.93B
| $14.7M | 0.03% |
751,942
+58,202
| +8% | +$1.02M |
|
657
Cummins
CMI
$78.6B
| $14.6M | 0.03% |
132,666
-219,634
| -62% | -$21.2M |
|
|
ACOR
658
DELISTED
Acorda Therapeutics
ACOR
| $14.4M | 0.03% |
4,546
+3,113
| +217% | +$12.9M |
|
659
GE Aerospace
GE
$354B
| $14.4M | 0.03% |
94,207
-68,610
| -42% | -$9.69M |
|
|
PRMW
660
DELISTED
Primo Water Corporation
PRMW
| $14.3M | 0.03% |
1,029,703
-19,854
| -2% | -$226K |
|
661
Philips
PHG
$26.8B
| $14.3M | 0.03% |
699,309
+688,081
| +6,128% | +$12.7M |
|
662
CALL
AbbVie
ABBV
$467B
| $14.3M | 0.03% |
249,800
-91,500
| -27% | -$5.1M |
|
663
CALL
Altria Group
MO
$114B
| $14.3M | 0.03% |
227,600
+98,700
| +77% | +$5.97M |
|
664
Pentair
PNR
$10.1B
| $14.2M | 0.03% |
390,788
-179,642
| -31% | -$5.81M |
|
665
Textron
TXT
$14.1B
| $14.2M | 0.03% |
390,575
+73,667
| +23% | +$2.58M |
|
|
ATHN
666
DELISTED
Athenahealth, Inc.
ATHN
| $14.2M | 0.03% |
102,284
-4,687
| -4% | -$643K |
|
667
Globalstar
GSAT
$10.7B
| $14.1M | 0.03% |
640,065
+9,892
| +2% | +$188K |
|
668
Autohome
ATHM
$2.5B
| $14.1M | 0.03% |
505,004
+143,902
| +40% | +$3.78M |
|
669
Cal-Maine
CALM
$4B
| $14M | 0.03% |
270,617
+265,236
| +4,929% | +$13.2M |
|
670
Charles River Laboratories
CRL
$14B
| $14M | 0.03% |
184,728
-52,091
| -22% | -$3.86M |
|
671
Tanger
SKT
$4.42B
| $14M | 0.03% |
384,790
-12,578
| -3% | -$414K |
|
|
AXE
672
DELISTED
Anixter International Inc
AXE
| $14M | 0.03% |
268,374
+57,829
| +27% | +$2.72M |
|
|
XLNX
673
DELISTED
Xilinx Inc
XLNX
| $14M | 0.03% |
294,357
+16,109
| +6% | +$756K |
|
674
CALL
Molson Coors Class B
TAP
$8.04B
| $13.9M | 0.03% |
144,900
-130,000
| -47% | -$11.6M |
|
675
Churchill Downs
CHDN
$6.36B
| $13.9M | 0.03% |
565,158
-13,974
| -2% | -$319K |
|
Similar funds
David Shaw's Q1 2016 Portfolio in Review
As of Q1 2016, David Shaw held 4,137 positions worth $55.7B, down 17% from $67.2B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
David Shaw withdrew a net $9.72B in Q1 2016, closing 773 positions and reducing 1,495 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $637M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
Against the trend, David Shaw opened a new position in EQT Corp worth $47.6M.
- David Shaw's largest Q1 2016 buy was EQT Corp: 1,300,361 shares worth $47.6M.
- David Shaw added most to Allergan plc in Q1 2016, an estimated $397M increase.
- David Shaw's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $358M.
- David Shaw fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $637M.
- David Shaw's ten largest holdings make up 9.5% of its $55.7B portfolio in Q1 2016.
- David Shaw opened 382 new positions and closed 773 in Q1 2016.
- David Shaw's portfolio value fell 17% quarter-over-quarter to $55.7B.
Based on D.E. Shaw & Co's 13F filing for Q1 2016, filed 16 May 2016.